Ocrelizumab: its efficacy and safety in multiple sclerosis
{{output}}
Introduction: Ocrelizumab is a humanised monoclonal antibody that targets the CD20 antigen on B cells. It has recently been approved by the US (Food and Drug Administration) and European health agencies (European Medicines Agency... ...
